Messikomer, A; Bruktawit, M; Seipel, Katja; Valk, P; Theocharides, A; Pabst, Thomas; Mckeague, M; Luedtke, N (25 May 2021). Cancer Prognosis According to Parthanatos Features (bioRxiv). Cold Spring Harbor Laboratory 10.1101/2021.05.24.445484
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
2021.05.24.445484v1.full.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (2MB) |
Messikommer and co-workers report that PARP-1-mediated programmed cell death is associated with successful, front-line treatment of acute myeloid leukemia (AML).
Item Type: |
Working Paper |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology |
UniBE Contributor: |
Seipel, Katja, Pabst, Thomas Niklaus |
Subjects: |
600 Technology > 610 Medicine & health |
Series: |
bioRxiv |
Publisher: |
Cold Spring Harbor Laboratory |
Language: |
English |
Submitter: |
Rebeka Gerber |
Date Deposited: |
24 Jan 2022 14:47 |
Last Modified: |
05 Dec 2022 16:02 |
Publisher DOI: |
10.1101/2021.05.24.445484 |
BORIS DOI: |
10.48350/164185 |
URI: |
https://boris.unibe.ch/id/eprint/164185 |
Actions (login required)
 |
Edit item |